In a groundbreaking development for the robotics industry, French company Wandercraft has raised $75 million in a Series D funding round to accelerate the development of AI-powered humanoid robots and self-balancing exoskeletons. This significant investment, announced on June 11, 2025, underscores the growing interest in advanced robotic solutions for both healthcare and industrial applications.
Wandercraft, known for its innovative mobility systems, aims to enhance its flagship products, including the Atalante exoskeleton, which assists individuals with mobility impairments such as spinal cord injuries and stroke survivors. The company is also expanding into industrial applications with creations like the Calvin 40, a utilitarian humanoid robot designed for factory tasks.
The funding will support the integration of cutting-edge AI technology, refined through billions of simulations, to improve the functionality and accessibility of these robotic systems. Additionally, strategic partnerships, such as the recent collaboration with Renault Group, aim to co-develop solutions that boost automation and worker safety in industrial settings.
This investment round positions Wandercraft as a leader in the next generation of robotics, aligning with global sustainability goals by leveraging AI to address critical societal needs. The company’s dual focus on healthcare and industry applications highlights its potential to transform lives and workplaces alike.
As Wandercraft continues to innovate, the robotics community watches closely, anticipating how these advancements will redefine mobility and automation. The company’s commitment to hands-free, self-balancing systems could set new standards in personal and industrial robotics.
For more details on this transformative funding, visit the original announcement on VentureBeat.
Alfred Lee
